FBXL10 regulates cardiac dysfunction in diabetic cardiomyopathy via the PKC β2 pathway

Diabetic cardiomyopathy (DCM) is a condition associated with significant structural changes including cardiac tissue necrosis, localized fibrosis, and cardiomyocyte hypertrophy. This study sought to assess whether and how FBXL10 can attenuate DCM using a rat streptozotocin (STZ)‐induced DCM model sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Leilei, Fang, Yingying, Song, Tao, Lv, Dan, Wang, Zheng, Zhu, Li, Zhao, Zihui, Yin, Xinhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433654/
https://www.ncbi.nlm.nih.gov/pubmed/30701683
http://dx.doi.org/10.1111/jcmm.14146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433654/
https://www.ncbi.nlm.nih.gov/pubmed/30701683
http://dx.doi.org/10.1111/jcmm.14146

Ejemplares similares